share_log

Bellerophon Therapeutics | SC 13D/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%), etc.

Bellerophon Therapeutics | SC 13D/A:超過5%持股股東披露文件(修正)-Theodore Wang(10.9%),Puissance Life Science Opportunities Fund VI(10.3%)等

SEC announcement ·  2023/06/07 21:44
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息